Struggling with Asthma
The ZION clinical study is investigating a new potential treatment for adults with COPD. Click below to find out if you're prequalified!
What is the RAINIER study?
For adults with Asthma
This study is investigating the medication solrikitug for its safety and effective treatment of asthma in adults. This drug works by blocking a chain reaction in the immune system that contributes to inflammation, which can lead to a flare-up.
How the RAINIER study works
Qualifying participants will be enrolled at a local study site, where healthcare professionals will oversee the under-the-skin injection of either the study drug or a placebo. This study takes place over 10 visits to the study site. The total time, including follow-up, is 28 weeks
Interested in learning more? Take the survey and find out if you are prequalified in just minutes
Living with Asthma
Do you have difficulty breathing?
Asthma can cause shortness of breath, wheezing, chronic coughing, and chest tightness. Any of these symptoms can stand in the way of a great day or a good night's sleep.
Are you constantly worried about asthma triggers?
Asthma sufferers are often sensitive to common allergens like dust or pollen, and it can be hard to know when symptoms can be triggered.
Is asthma holding you back?
Other symptoms of asthma might include difficulty sleeping, feeling fatigued, difficulty exercising, anxiety, and more.
The RAINIER clinical study is investigating a potential treatment that may help reduce some symptoms of asthma. To find out how you may be able to participate, click the button below.
Who is eligible?
